Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 14 / 2024
Date of issue: 2024-03-22
Short name of the issuer
KRKA
Subject
Information on the appointment of employee representatives to the supervisory board
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) discloses information regarding the election of employee representatives to the Supervisory Board.

At its 11th regular meeting on 20 March 2024, the Krka Workers' held elections for members of the Krka Supervisory Board, employee representatives. The mandate of the current employee representatives expires on June 21 this year.

Mateja Vrečer, Tomaž Sever and Mari Božič were elected to the Supervisory Board as employee representatives. Employee representatives are appointed to the supervisory board for a mandate period of five years, which begins on June 21 this year.

This announcement will be published on the company’s website (www.krka.biz) starting from 27 November 2023, for a minimum period of 5 years.
Annexes
File Description

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-03-22 Jože Colarič President of the Management Board and CEO